KRAS Mutations and Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer With Lymph Node Metastases

被引：11
作者：
Velho, Sergia [1 ]
Oliveira, Carla [1 ,2 ]
Seruca, Raquel [1 ,2 ]
机构：
[1] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal
[2] Univ Porto, Fac Med, P-4100 Oporto, Portugal
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 01期
关键词：
CETUXIMAB; PANITUMUMAB; BRAF;
D O I：
10.1200/JCO.2008.20.1525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：158 / 159
页数：3
相关论文
共 50 条
  • [41] To Give or Not to Give Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal Cancer
    Kim, Richard
    Kubal, Timothy
    CLINICAL COLORECTAL CANCER, 2012, 11 (02) : 85 - 87
  • [42] Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer
    Yamada, Tadaaki
    Takeuchi, Shinji
    Kita, Kenji
    Bando, Hideaki
    Nakamura, Takahiro
    Matsumoto, Kunio
    Yano, Seiji
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (02) : 272 - 280
  • [43] Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer=70 years
    Papamichael, Demetris
    Lopes, Guilherme S.
    Olswold, Curt L.
    Douillard, Jean-Yves
    Adams, Richard A.
    Maughan, Timothy S.
    Van Cutsem, Eric
    Venook, Alan P.
    Lenz, Heinz-Josef
    Heinemann, Volker
    Kaplan, Richard
    Bokemeyer, Carsten
    Chibaudel, Benoist
    Grothey, Axel
    Yoshino, Takayuki
    Zalcberg, John
    De Gramont, Aimery
    Shi, Qian
    EUROPEAN JOURNAL OF CANCER, 2022, 163 : 1 - 15
  • [44] Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer
    G Galizia
    E Lieto
    F De Vita
    M Orditura
    P Castellano
    T Troiani
    V Imperatore
    F Ciardiello
    Oncogene, 2007, 26 : 3654 - 3660
  • [45] Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer
    Takahashi, Naoki
    Yamada, Yasuhide
    Furuta, Koh
    Nagashima, Kengo
    Kubo, Akiko
    Sasaki, Yusuke
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    CANCER SCIENCE, 2015, 106 (05) : 604 - 610
  • [46] Role of Anti-Epidermal Growth Factor Receptor Therapy Compared with Anti-Vascular Endothelial Growth Factor Therapy for Metastatic Colorectal Cancer: an Update Meta-Analysis of Randomized Clinical Trials
    Wang, Jian-Xiang
    Wu, Hai-Long
    Zhu, Meng
    Zhou, Rui
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) : 159 - 166
  • [47] Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer
    Galizia, G.
    Lieto, E.
    De Vita, F.
    Orditura, M.
    Castellano, P.
    Troiani, T.
    Imperatore, V.
    Ciardiello, F.
    ONCOGENE, 2007, 26 (25) : 3654 - 3660
  • [48] Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
    Sobani, Zain A.
    Sawant, Ashwin
    Jafri, Mikram
    Correa, Amit Keith
    Sahin, Ibrahim Halil
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (05): : 340 - 351
  • [49] Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab
    Sartore-Bianchi, Andrea
    Sporchia, Andrea
    Cerea, Giulio
    Maugeri, Maria Rosaria
    Cipani, Tiziana
    Andreotti, Ines
    Marrapese, Giovanna
    Artale, Salvatore
    Siena, Salvatore
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 249 - 254
  • [50] Risk Factor Analysis for Anti-epidermal Growth Factor Receptor Monoclonal Antibody-induced Problematic Skin Toxicities in Patients With Liver Metastatic Colorectal Cancer
    Saito, Yoshitaka
    Uchiyama, Kazuki
    Takekuma, Yoh
    Komatsu, Yoshito
    Sugawara, Mitsuru
    IN VIVO, 2024, 38 (05): : 2390 - 2398
12345